EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

MYD88 L265P Variant Detection with Droplet Digital PCR in Waldenström Macroglobulinemia: Clinical Implications as a Tumor Burden and Prognostic Marker

Woo Jin Shin iD, Yoo Jin Kang iD, Aram Kim iD, Jeong-Ok Lee iD, Sang Mee Hwang iD

Annals of Laboratory Medicine · 2025

DOI: 10.3343/alm.2024.0644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2025. Verfasst von Woo Jin Shin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Biomarkers, Tumor, Myeloid Differentiation Factor 88, Bone Marrow. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul National University Bundang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Waldenström macroglobulinemia (WM) is a B-cell lymphoproliferative disease characterized by IgM monoclonal gammopathy and bone marrow (BM) infiltration caused by lymphoplasmacytic lymphoma. The MYD88 L265P variant is present in >90% of WM cases. We used droplet digital PCR (ddPCR) to detect MYD88 L265P in initial BM samples from 15 patients with WM and assessed the implication of variant burden as a tumor load and prognostic marker. MYD88 L265P burden correlated with clinical indicators, including peripheral blood and BM lymphocyte percentages (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waldenstrom MacroglobulinemiaBiomarkers, TumorMyeloid Differentiation Factor 88Bone MarrowTumor BurdenPrognosisPolymerase Chain ReactionPlatelet CountL-Lactate DehydrogenaseRetrospective StudiesMutationHumansMaleFemaleMiddle AgedAgedAged, 80 and overFollow-Up StudiesTreatment OutcomeDisease Progression

Stichwörter der Autor:innen

Droplet digital PCRMYD88 L265P variantWaldenström macroglobulinemia

Substanzen

MYD88 protein, humanBiomarkers, TumorMyeloid Differentiation Factor 88L-Lactate Dehydrogenase

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

ORCID-Profile: Woo Jin Shin, Yoo Jin Kang, Aram Kim, Jeong-Ok Lee, Sang Mee Hwang

Förderung

  • Seoul National University Bundang Hospital

Zitieren

APA

Shin, W. J., Kang, Y. J., Kim, A., Lee, J. O., & Hwang, S. M. (2025). MYD88 L265P Variant Detection with Droplet Digital PCR in Waldenström Macroglobulinemia: Clinical Implications as a Tumor Burden and Prognostic Marker. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2024.0644

Vancouver

Shin WJ, Kang YJ, Kim A, Lee JO, Hwang SM. MYD88 L265P Variant Detection with Droplet Digital PCR in Waldenström Macroglobulinemia: Clinical Implications as a Tumor Burden and Prognostic Marker. Annals of Laboratory Medicine. 2025. doi:10.3343/alm.2024.0644

BibTeX
@article{Shin2025,
  author = {Shin, Woo Jin and Kang, Yoo Jin and Kim, Aram and Lee, Jeong-Ok and Hwang, Sang Mee},
  title = {MYD88 L265P Variant Detection with Droplet Digital PCR in Waldenström Macroglobulinemia: Clinical Implications as a Tumor Burden and Prognostic Marker},
  journal = {Annals of Laboratory Medicine},
  year = {2025},
  doi = {10.3343/alm.2024.0644}
}
Kostenlos starten →